Novo Nordisk
Anna Maria Malberg Tetzschner, PhD, is currently a Senior Scientist at Novo Nordisk since March 2023. Previously, Anna Maria served as a Geneticist/Bioinformatician at Statens Serum Institut from June 2020 to March 2023 and worked as a Bioinformatician at Amager og Hvidovre Hospital from August 2019 to June 2020. Anna Maria's academic background includes a PhD and a Master's degree in Biotechnology from the Technical University of Denmark, as well as experience as a PhD student at the Center for Biological Sequence Analysis. Additionally, Anna Maria held positions as a Quality Coordinator and Master Thesis Student at Speciallægeselskabet Tetzschner ApS and Statens Serum Institut, respectively. Early career roles included Environmental Clerk positions at Greenland Contractors.
This person is not in the org chart
This person is not in any teams
Novo Nordisk
379 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.